Arama Sonuçları - Bruce R. Blazar

Sonuçları Daraltın
  1. 1
    Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?

    Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Yazar: Robert Zeiser, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

    Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy Yazar: Robert Zeiser, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  3. 3
    How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD

    How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD Yazar: Samantha Jaglowski, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Acute graft-versus-host disease: from the bench to the bedside

    Acute graft-versus-host disease: from the bench to the bedside Yazar: Gèrard Socié, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    T CELL DEPLETION FOR GRAFT-VERSUS-HOST-DISEASE PROPHYLAXIS

    T CELL DEPLETION FOR GRAFT-VERSUS-HOST-DISEASE PROPHYLAXIS Yazar: Daniel A. Vallera, Bruce R. Blazar

    Baskı/Yayın Bilgisi 1989
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  6. 6
    ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease

    ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease Yazar: Alexandra Zanin‐Zhorov, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Pathogenesis of acute graft‐versus‐host disease: from intestinal microbiota alterations to donor T cell activation

    Pathogenesis of acute graft‐versus‐host disease: from intestinal microbiota alterations to donor T cell activation Yazar: Robert Zeiser, Gèrard Socié, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  8. 8
    B-cell targeting in chronic graft-versus-host disease

    B-cell targeting in chronic graft-versus-host disease Yazar: Robert Zeiser, Stefanie Sarantopoulos, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Thymic T-cell development in allogeneic stem cell transplantation

    Thymic T-cell development in allogeneic stem cell transplantation Yazar: Werner Krenger, Bruce R. Blazar, Georg A. Holländer

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Advances in graft-versus-host disease biology and therapy

    Advances in graft-versus-host disease biology and therapy Yazar: Bruce R. Blazar, William J. Murphy, Mehrdad Abedi

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Recent advances in graft‐versus‐host disease (GVHD) prevention

    Recent advances in graft‐versus‐host disease (GVHD) prevention Yazar: Bruce R. Blazar, Robert Korngold, Andrea R. Daniel

    Baskı/Yayın Bilgisi 1997
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells

    Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells Yazar: Jakub Tolar, Keli L. Hippen, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Emerging strategies to boost thymic function

    Emerging strategies to boost thymic function Yazar: Georg A. Holländer, Werner Krenger, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Advances in targeting co‐inhibitory and co‐stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy

    Advances in targeting co‐inhibitory and co‐stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy Yazar: Leslie S. Kean, Laurence A. Turka, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Busulfan disposition in children

    Busulfan disposition in children Yazar: LB Grochow, William Krivit, CB Whitley, Bruce R. Blazar

    Baskı/Yayın Bilgisi 1990
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    B Cells in Chronic Graft-versus-Host Disease

    B Cells in Chronic Graft-versus-Host Disease Yazar: Stefanie Sarantopoulos, Bruce R. Blazar, Corey Cutler, Jerome Ritz

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Engineering lymphocyte subsets: tools, trials and tribulations

    Engineering lymphocyte subsets: tools, trials and tribulations Yazar: Carl H. June, Bruce R. Blazar, James L. Riley

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  18. 18
    PKC-θ function at the immunological synapse: prospects for therapeutic targeting

    PKC-θ function at the immunological synapse: prospects for therapeutic targeting Yazar: Alexandra Zanin‐Zhorov, Michael L. Dustin, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  19. 19
    CD4+ AND CD8+ T CELLS EACH CAN UTILIZE A PERFORIN-DEPENDENT PATHWAY TO MEDIATE LETHAL GRAFT-VERSUS-HOST DISEASE IN MAJOR HISTOCOMPATIBILITY COMPLEX-DISPARATE RECIPIENTS1

    CD4+ AND CD8+ T CELLS EACH CAN UTILIZE A PERFORIN-DEPENDENT PATHWAY TO MEDIATE LETHAL GRAFT-VERSUS-HOST DISEASE IN MAJOR HISTOCOMPATIBILITY COMPLEX-DISPARATE RECIPIENTS1 Yazar: Bruce R. Blazar, Patricia A. Taylor, Daniel A. Vallera

    Baskı/Yayın Bilgisi 1997
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality

    The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality Yazar: Patricia A. Taylor, Christopher J. Lees, Bruce R. Blazar

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: